Who owns Capstone Therapeutics Corporat?
- Ticker: CAPS
- CUSIP Number: 14068e208
Tip: Access positions for across all investors
Analyze quarterly positions in Capstone Therapeutics Corporat with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Capstone Therapeutics Corporat stock
Who bought or sold Capstone Therapeutics Corporat this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DRW Holdings | 125k | $91k | 100% | Dec 2025 |
|
| Citadel Advisors | 16k | $21k | 100% | Sep 2025 |
|
| Two Sigma Investments | 11k | $14k | 2% | Sep 2025 |
|
| UBS Group | 2.5k | $1.8k | -1% | Dec 2025 |
|
| KERR FINANCIAL PLANNING Corp | 75.00 | $363.997500 | 100% | Dec 2025 |
|
Who sold out of Capstone Therapeutics Corporat?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pensionmark Financial Group | Sep 2025 | 29k | $38k |
| Two Sigma Securities | Sep 2025 | 12k | $15k |
| Tower Research Capital | Sep 2025 | 5.5k | $7.3k |